In April 2024, college student Sade Robinson, 19, went on a first date and never came home. Her car was found set on fire 3 ...

President Trump suggested in an interview with former FBI Deputy Director Dan Bongino on Monday that Republicans should “take over” the voting process in more than a dozen states ahead of the November ...

Ricursive Intelligence, a startup building an AI system to design and automatically improve AI chips, has raised $300 million at a $4 billion valuation. The company said Monday the round was led by ...

Atlanta Falcons running back Bijan Robinson (7) celebrates after a victory over the Los Angeles Rams at Mercedes-Benz Stadium. Credit: Brett Davis-Imagn Images With only a few weeks left of NFL games ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...

China introduced its first national standard for solid-state EV batteries as the “holy grail” of battery tech moves closer toward mass production. China launches solid-state EV battery national ...

2025 was supposed to be the year where the Washington Nationals broke through a bit. After two straight seasons where they won 71 games, the optimism heading into this past campaign was fairly high ...

Do you make new year's resolutions? Many of us do, but most of the time we don't write them down. You get winded climbing a single flight of stairs, and your body tells you, "Work out! You are in ...

The Colorado Rockies are starting to build towards the future; that much is clear. With a completely overhauled front office, the team is now looking to put together an improved roster following one ...

After trading their first round selection for General Allocation Money to start the afternoon, the New England Revolution kept and used their second and third-round picks in Thursday’s MLS SuperDraft.

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...